Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation SystemCompleted
NCT02439775NAUpdated Jul 30, 2026
Sponsor: Medtronic Vascular
Hypertension · Vascular Diseases · Cardiovascular Diseases
United States, Australia, Austria, Canada, France +5 more
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension PeriodActive Not Recruiting
NCT05144256Phase 3Updated Jul 30, 2026
Sponsor: Agios Pharmaceuticals, Inc.
Pediatric Pyruvate Kinase Deficiency · Pediatric Hemolytic Anemia
United States, Canada, Czechia, Denmark, Germany +5 more
The DefiPace StudyRecruiting
NCT04804748N/AUpdated Jul 30, 2026
Sponsor: Institut für Pharmakologie und Präventive Medizin
Post-operative Atrial Fibrillation POAF
Austria, Germany
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaRecruiting
NCT03970447Phase 2, Phase 3Updated Jul 30, 2026
Sponsor: Global Coalition for Adaptive Research
Glioblastoma
United States, Australia, Canada, France, Germany +1 more
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of RecurrenceRecruiting
NCT06830720N/AUpdated Jul 30, 2026
Sponsor: Novartis Pharmaceuticals
Breast Neoplasms
Austria, Germany
REDUCER-I: An Observational Study of the Neovasc Reducer™ SystemActive Not Recruiting
NCT02710435N/AUpdated Jul 30, 2026
Sponsor: Shockwave Medical, Inc.
Angina Pectoris · Angina Pectoris, Stable · Chronic Stable Angina
Austria, Belgium, France, Germany, Italy +4 more
Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac SurgeryRecruiting
NCT04241328N/AUpdated Jul 30, 2026
Sponsor: Medtronic Cardiac Surgery
Cardiovascular Diseases
Austria, Belgium, France, Germany, Greece +3 more
Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA ValveRecruiting
NCT06953206N/AUpdated Jul 30, 2026
Sponsor: Institut für Pharmakologie und Präventive Medizin
Transcatheter Aortic Valve Replacement (TAVR) · Aortic-Stenosis · Aortic Insufficiency · Degenerative Valve Disease
Germany
Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCLCompleted
NCT04263584Phase 2Updated Jul 30, 2026
Sponsor: University Hospital Muenster
Diffuse Large B Cell Lymphoma
Germany
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery DiseaseActive Not Recruiting
NCT05755711N/AUpdated Jul 30, 2026
Sponsor: Shockwave Medical, Inc.
Coronary Artery Disease
United States, France, Germany, Spain, United Kingdom
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial FibrillationNot Yet Recruiting
NCT07625215Phase 2Updated Jul 30, 2026
Sponsor: Bayer
Atrial Fibrillation
United States, Belgium, Bulgaria, Germany, Hungary +3 more
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettINGRecruiting
NCT06712628N/AUpdated Jul 30, 2026
Sponsor: AbbVie
Moderate to Severe Rheumatoid Arthritis
Germany
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisRecruiting
NCT06598943Phase 2Updated Jul 30, 2026
Sponsor: Eli Lilly and Company
Ulcerative Colitis · Ulcerative Colitis Chronic
United States, Argentina, Belgium, Canada, Colombia +16 more
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)Recruiting
NCT06170788Phase 3Updated Jul 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Brazil, Canada +21 more
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideActive Not Recruiting
NCT06208150Phase 3Updated Jul 30, 2026
Sponsor: Janssen Research & Development, LLC
Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +22 more
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.Recruiting
NCT07215702Phase 2Updated Jul 30, 2026
Sponsor: AstraZeneca
Sepsis · Acute Kidney Injury
United States, Argentina, Belgium, Canada, Czechia +9 more
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive ParticipantsActive Not Recruiting
NCT02938520Phase 3Updated Jul 30, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States, Canada, France, Germany, Italy +6 more
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the CancerCompleted
NCT02632409Phase 3Updated Jul 30, 2026
Sponsor: Bristol-Myers Squibb
Various Advanced Cancer
United States, Argentina, Australia, Austria, Belgium +25 more
A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaEnrolling By Invitation
NCT07204938Phase 3Updated Jul 30, 2026
Sponsor: Astria Therapeutics, Inc.
Hereditary Angioedema (HAE)
United States, Brazil, Bulgaria, Canada, Czechia +13 more
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) StudyActive Not Recruiting
NCT04620239Phase 3Updated Jul 30, 2026
Sponsor: Steba Biotech S.A.
Transitional Cell Cancer of Renal Pelvis and Ureter
United States, France, Germany, Israel, Spain
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionCompleted
NCT06034743Phase 3Updated Jul 30, 2026
Sponsor: AstraZeneca
Uncontrolled Hypertension · Resistant Hypertension
United States, Argentina, Australia, Austria, Belgium +24 more
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisRecruiting
NCT07039916Phase 3Updated Jul 30, 2026
Sponsor: Immunovant Sciences GmbH
Generalized Myasthenia Gravis
United States, Argentina, Czechia, Denmark, Georgia +10 more
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaEnrolling By Invitation
NCT07256392Phase 3Updated Jul 29, 2026
Sponsor: Celldex Therapeutics
Chronic Spontaneous Urticaria
United States, Argentina, Australia, Belgium, Bulgaria +14 more
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 StudyActive Not Recruiting
NCT06534892Phase 3Updated Jul 29, 2026
Sponsor: GlaxoSmithKline
Respiratory Syncytial Virus Infections
United States, Australia, Belgium, Canada, Estonia +12 more
Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular EdemaCompleted
NCT04543331N/AUpdated Jul 29, 2026
Sponsor: Novartis Pharmaceuticals
Neovascular Age-related Macular Degeneration (nAMD) · Diabetic Macular Edema (DME)
Germany

Previous page Next page